Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire

Am J Trop Med Hyg. 2021 Apr 5;104(5):1782-1783. doi: 10.4269/ajtmh.20-1307.

Abstract

Mycobacterium ulcerans, the opportunistic pathogen causing Buruli ulcer, is reported to affect rural populations in 36 tropical countries. We report one case of Buruli ulcer in a peri-urban area in Côte d'Ivoire, confirmed by whole genome sequencing which indicated a M. ulcerans genotype previously unreported in Côte d'Ivoire.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / therapeutic use
  • Buruli Ulcer / diagnosis*
  • Buruli Ulcer / drug therapy
  • Buruli Ulcer / microbiology
  • Buruli Ulcer / pathology
  • Cities
  • Cote d'Ivoire
  • Genome, Bacterial*
  • Genotype*
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium ulcerans / classification
  • Mycobacterium ulcerans / drug effects
  • Mycobacterium ulcerans / genetics*
  • Mycobacterium ulcerans / pathogenicity
  • Phylogeny
  • Rifampin / therapeutic use
  • Whole Genome Sequencing

Substances

  • Anti-Bacterial Agents
  • Azithromycin
  • Rifampin